http://www.cnr.it/ontology/cnr/individuo/prodotto/ID21161
Receptor tyrosine kinase inhibitors in thyroid cancer. (Articolo in rivista)
- Type
- Label
- Receptor tyrosine kinase inhibitors in thyroid cancer. (Articolo in rivista) (literal)
- Anno
- 2008-01-01T00:00:00+01:00 (literal)
- Alternative label
Castellone MD, Carlomagno F, Salvatore G, Santoro M. (2008)
Receptor tyrosine kinase inhibitors in thyroid cancer.
(literal)
- Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#autori
- Castellone MD, Carlomagno F, Salvatore G, Santoro M. (literal)
- Pagina inizio
- Pagina fine
- Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#numeroVolume
- Note
- ISI Web of Science (WOS) (literal)
- Titolo
- Receptor tyrosine kinase inhibitors in thyroid cancer. (literal)
- Abstract
- Thyroid cancer is frequently associated with the oncogenic conversion of receptor tyrosine kinases (RTKs) or their downstream signalling molecules. Hence, there is a strong biological rationale for assessing the efficacy of RTK blockade to treat patients who are resistant to or not candidates for treatment with radioactive iodine. The first results of clinical trials based on the use of RTK inhibitors in thyroid cancer patients have recently been published. Here we discuss targeting of specific RTKs as a potential therapeutic strategy for the treatment of thyroid cancer.
(literal)
- Prodotto di
- Autore CNR
Incoming links:
- Autore CNR di
- Prodotto